Published in AJR Am J Roentgenol on February 01, 1997
Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol (2014) 2.27
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg (2004) 1.87
Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer (2008) 1.69
Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer. Eur J Nucl Med Mol Imaging (2006) 1.67
Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer (1998) 1.01
FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer. Eur J Nucl Med Mol Imaging (2006) 1.00
Imaging of esophageal cancer. Cancer Imaging (2004) 0.99
Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach? World J Surg (2003) 0.96
The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer. Gastrointest Cancer Res (2008) 0.93
The Feasibility of (18)F-Fluorothymidine PET for Prediction of Tumor Response after Induction Chemotherapy Followed by Chemoradiotherapy with S-1/Oxaliplatin in Patients with Resectable Esophageal Cancer. Nucl Med Mol Imaging (2012) 0.89
Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis. World J Surg (2002) 0.89
Technological advances in radiotherapy for esophageal cancer. World J Gastroenterol (2010) 0.86
Surgical management of esophageal carcinoma. Proc (Bayl Univ Med Cent) (2003) 0.86
Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings. Int J Clin Oncol (2009) 0.84
Current role of positron emission tomography in thoracic oncology. Thorax (1998) 0.84
Hounsfield units upon PET/CT are useful in evaluating metastatic regional lymph nodes in patients with oesophageal squamous cell carcinoma. Br J Radiol (2011) 0.82
Role of F18-FDG PET/CT in the Staging and Restaging of Esophageal Cancer: A Comparison with CECT. Indian J Surg Oncol (2012) 0.82
18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies. Gut (2003) 0.81
Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer. J Radiat Res (2013) 0.80
State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment. J Gastrointest Oncol (2015) 0.80
PET/CT planning during chemoradiotherapy for esophageal cancer. Radiat Oncol J (2014) 0.78
Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia. World J Surg (2003) 0.77
Clinical significance of incidental findings on staging positron emission tomography for oesophagogastric malignancies. Ann R Coll Surg Engl (2014) 0.77
Radiologist experience and CT examination quality determine metastasis detection in patients with esophageal or gastric cardia cancer. Eur Radiol (2008) 0.75
8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg (2017) 0.75
Positron emission tomography-computed tomography of esophageal adenocarcinoma with vascular invasion and tumor thrombus. Proc (Bayl Univ Med Cent) (2011) 0.75
Factors Predicting Effectiveness of Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma. Medicine (Baltimore) (2016) 0.75
Overview of esophageal cancer. Ann Cardiothorac Surg (2017) 0.75
Patients' perception of diagnostic tests in the preoperative assessment of esophageal cancer. Patient Prefer Adherence (2008) 0.75
The 100 most cited articles investigating the radiological staging of oesophageal and junctional cancer: a bibliometric analysis. Insights Imaging (2016) 0.75
Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet (2011) 3.70
Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun (2008) 3.48
Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med (1990) 2.85
CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun (2008) 2.76
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69
MR imaging of diffusion of (3)He gas in healthy and diseased lungs. Magn Reson Med (2000) 2.55
Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (1995) 2.44
Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg (2001) 2.40
The evolution of tracheal injury due to ventilatory assistance through cuffed tubes: a pathologic study. Ann Surg (1969) 2.28
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol (2001) 2.20
A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant (2007) 2.16
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2001) 2.15
Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg (1996) 2.15
Cost-effective analysis of candidate genes using htSNPs: a staged approach. Genes Immun (2004) 2.07
Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg (1982) 1.99
FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol (2000) 1.96
No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia (2009) 1.92
Long-term clinical outcome after transcervical thymectomy for myasthenia gravis. Ann Thorac Surg (1998) 1.86
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med (2001) 1.80
Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. Clin Chem (1982) 1.79
Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol (1997) 1.77
Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med (1990) 1.77
Experience with primary neoplasms of the trachea and carina. J Thorac Cardiovasc Surg (1984) 1.75
Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys (1991) 1.65
Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol (2001) 1.64
CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant (2006) 1.63
Massive hiatal hernia with incarceration: a report of 53 cases. Ann Thorac Surg (1983) 1.60
The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg (1999) 1.59
Primary tracheal anastomosis after resection of the cricoid cartilage with preservation of recurrent laryngeal nerves. J Thorac Cardiovasc Surg (1975) 1.58
Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery (2001) 1.57
Donor lung procurement: assessment and operative technique. Ann Thorac Surg (1993) 1.54
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]. Neurobiol Dis (1999) 1.54
Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg (1987) 1.54
Breast cancer: PET imaging of estrogen receptors. Radiology (1988) 1.53
Experimental production and prevention of injury due to cuffed tracheal tubes. Surg Gynecol Obstet (1969) 1.53
Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med (1999) 1.49
Lung volume reduction surgery: comparison of preoperative radiologic features and clinical outcome. Radiology (1997) 1.48
Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg (1986) 1.47
Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg (2000) 1.46
Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg (1991) 1.46
Ventilation-perfusion studies in suspected pulmonary embolism. AJR Am J Roentgenol (1979) 1.45
Outcome of Medicare patients with emphysema selected for, but denied, a lung volume reduction operation. Ann Thorac Surg (1998) 1.45
Elevations of CK-MB following pulmonary embolism. A manifestation of occult right ventricular infarction. Chest (1992) 1.44
Dominoes--pragmatism or piracy? Transpl Int (1991) 1.44
Single lung transplantation and closure of patent ductus arteriosus for Eisenmenger's syndrome. Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1990) 1.42
Determination of blood ethanol by gas chromatography. Clin Chim Acta (1971) 1.42
Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection. J Heart Lung Transplant (1997) 1.41
HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation (1998) 1.41
Preharvest nitroprusside flush improves posttransplantation lung function. J Heart Lung Transplant (1997) 1.40
The donor lung: infectious and pathologic factors affecting outcome in lung transplantation. J Thorac Cardiovasc Surg (1993) 1.39
Strategies to increase limited donor resources. Eur Respir J (2004) 1.38
Afferent and efferent connections of the laterodorsal tegmental nucleus in the rat. Brain Res Bull (1990) 1.37
Separate extraction of cardiac and pulmonary grafts from a single organ donor. Ann Thorac Surg (1988) 1.37
Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg (1990) 1.36
Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res (1996) 1.35
Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron (1996) 1.35
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med (1995) 1.34
Diffusible Factors Essential for Epidermal Cell Redifferentiaion in Catharanthus roseus. Science (1989) 1.33
Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg (1998) 1.30
Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation (1999) 1.28
Tuberculous peritonitis--report of 30 cases and review of the literature. Q J Med (1985) 1.28
Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant (2005) 1.27
Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg (1998) 1.26
Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am J Pathol (1992) 1.25
Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. J Nucl Med (2001) 1.25
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum (2000) 1.25
Brain metastases from non-central nervous system tumors: evaluation with PET. Radiology (1993) 1.24
Double-lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis (1989) 1.23
Technique of successful clinical double-lung transplantation. Ann Thorac Surg (1988) 1.23
Evaluation of suicidal patients: the SAD PERSONS scale. Psychosomatics (1983) 1.22
Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol (1997) 1.22
RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J Nucl Med (1995) 1.21
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. J Nucl Med (1991) 1.21
Smoking cessation and lung cancer resection. Chest (1996) 1.21
Repeatability of quantitative CT indexes of emphysema in patients evaluated for lung volume reduction surgery. Radiology (2001) 1.20